November 4, 2026StocksTechnology·Bullish·clinical data

Kura Oncology and Kyowa Kirin to present eight ziftomenib abstracts at ASH 2026

Kura Oncology and Kyowa Kirin will present eight ziftomenib abstracts at ASH 2026, highlighting promising AML combination data and expanded clinical potential.

Detected & updated continuously · Source: Nebula

Story subjects

Kura Oncology, Inc.Kyowa Kirin

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula